Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapyAnna Nordenskjöld, Bo Nordenskjöld, Tommy� Fornander et al.|The Breast|2023Cited by 7
Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapyAnna Nordenskjöld, Bo Nordenskjöld, Helena Fohlin et al.|Research Square|2023Cited by 0